SUBSCRIBE
SUBSCRIBE
News   Business

Orbus Pharma Inc. Reports Third Quarter 2006 Results

November 6, 2006 | 
1 min read
TORONTO, ONTARIO--(CCNMatthews - Nov. 6, 2006) - Orbus Pharma Inc. (TSX:ORB) reported that the net loss for the first nine months of 2006 was $4,500 ($0.12 per share) compared to $5,091 ($0.17 per share) in 2005.
Earnings
MORE ON THIS TOPIC
Legal and law concept illustration stock illustration
GLP-1
Novo Sues Hims & Hers Over Compounded Version of Oral Wegovy Pill
February 9, 2026
 · 
2 min read
 · 
Tristan Manalac
Graphic drawing white background
Psychedelics
AbbVie CSO Touts ‘Breakthrough Type Therapy’ Psychedelic as J&J’s Spravato Keeps Growing
February 6, 2026
 · 
2 min read
 · 
Dan Samorodnitsky
Business meeting idea and planning with strategy as a corporate concept with a mechanical wheel bridge as diverse multiracial businesspeople joining together as a symbol for people diversity and success with 3D render elements.
Earnings
Biogen’s ‘Bridge To Growth’ Cuts Through a Stacked Phase 3 Pipeline
February 6, 2026
 · 
2 min read
 · 
Annalee Armstrong
IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch
IPO
Eikon Clocks Largest IPO Since 2024, Generate, AgomAb Follow
February 6, 2026
 · 
5 min read
 · 
Tristan Manalac